Whenever a pilot is prescribed or stops using either a new dosage of a medication or a new medication, the pilot must submit that information within 10 days to the physician appointed by the Board of Pilot Commissioners who has the pilot's prescribed medication list (that was previously submitted to the same Board of Pilot Commissioners appointed physician for the pilot's physical examination determining fitness for duty). Whenever the physician receives the updated information, the physician must determine whether the medication change affects the pilot's fitness for duty.
The State Authorized Risk Assessment Tool for Sex Offenders (SARATSO) shall be administered by the Department of Corrections and Rehabilitation to assess every eligible person who is incarcerated in state prison and every eligible person who is on parole if the person was not assessed prior to release from state prison). The Department of Mental Health shall administer the SARATSO to assess every eligible person who is committed to that department.
Commencing July 1, 2009, or within one year of the establishment of a state electronic laboratory reporting system, whichever is later, a report of a reportable disease or condition generated by a laboratory shall be submitted electronically in a manner specified by the Department of Public Health. This electronic reporting requirement shall not apply to reports of HIV infections. The department shall allow laboratories that receive incomplete patient information to report the name of the provider who submitted the request to the local health officer.
A provider of health care or a health care service plan may disclose medical information in the following circumstances: 1) to other healthcare providers to facilitate diagnosis and treatment 2) to find financially liable party and obtain payment 3) to administrative subcontractors 4) quality control organizations (peer review boards, etc.) 5) accrediting agencies 6) coroners 7) \bona fide research purposes\" 8) employer
Disclosure of HIV/AIDS records by a state or local public health agency for public health or research purposes shall be limited to the information necessary for the purpose of that disclosure, and shall be made only upon agreement that the information will be kept confidential and will not be further disclosed without written authorization of the subject or his/her guardian/conservator.
(a)-(b) All DNA and forensic identification profiles and other identification information or biological samples retained by the Department of Justice are exempt from any law requiring disclosure of information to the public or return of biological specimens, samples, or print impressions.
(b) A pharmacy receiving an electronic transmission prescription shall not be required to reduce that prescription to writing or to hard copy form if, for three years from the last date of furnishing pursuant to that prescription or order, the pharmacy is able, upon request by the board, to immediately produce a hard copy report that includes for each date of dispensing of a dangerous drug or dangerous device pursuant to that prescription or order: (1) all of the information described in subparagraphs (A) to (E), inclusive, of paragraph (1) of subdivision (a) of Section 4040, and (2) the name
If only recorded and stored electronically, on magnetic media, or in any other computerized form, the pharmacy's computer system shall not permit the received information or the dangerous drug or dangerous device dispensing information required by this section to be changed, obliterated, destroyed, or disposed of, for the records maintenance period required by law once the information has been received by the pharmacy and once the dangerous drug or dangerous device has been dispensed.
Owners and laboratory directors of all clinical laboratories shall preserve medical records and laboratory records, as defined in this section, for three years from the date of testing, examination, or purchase. Failure to retain records accordingly is cause of legal action. Information in these medical records shall be confidential, with certain exceptions.
Owners/directors of clinical labs shall preserve medical and lab records for at least 3 years. Information shall be confidential, disclosed only to authorized persons.
